首页> 外国专利> METHOD FOR CULTURING AND PROLIFERATING HEMATOPOIETIC STEM CELLS AND PROGENITOR CELLS USING HUMAN ENDOMETRIAL CELLS

METHOD FOR CULTURING AND PROLIFERATING HEMATOPOIETIC STEM CELLS AND PROGENITOR CELLS USING HUMAN ENDOMETRIAL CELLS

机译:用人子宫内膜细胞培养和增殖造血干细胞和祖细胞的方法

摘要

Disclosed herein is a method for culturing and proliferating hematopoietic stem cells or progenitor cells. The method comprises co-culturing the hematopoietic stem cells or the progenitor cells with human endometrial stromal cells so as to promote the expansion of hematopoietic stem cell-derived CD34+ cells or the growth of the progenitor cells. According to the disclosed method, unlike the prior methods of culturing the hematopoietic stem cells with the addition of cytokines, growth factors or hormones, the hematopoietic stem cells or the progenitor cells are co-cultured with the endometrial stromal cells or epithelial cells so that the number of CD34+-enriched hematopoietic stem cells or progenitor cells is increased by factors secreted from the endometrial stromal cells or epithelial cells. Accordingly, it is possible to eliminate the addition of growth factors, such as cytokines, and hormones, which cause problems in transplantation of hematopoietic stem cells or progenitor cells and thus safe hematopoietic stem cells or progenitor cells can be obtained in large amounts.
机译:本文公开了一种用于培养和增殖造血干细胞或祖细胞的方法。该方法包括将造血干细胞或祖细胞与人子宫内膜基质细胞共培养,以促进源自造血干细胞的CD34 +细胞的扩增或祖细胞的生长。根据公开的方法,与先前的通过添加细胞因子,生长因子或激素来培养造血干细胞的方法不同,将造血干细胞或祖细胞与子宫内膜基质细胞或上皮细胞共培养,使得富集CD34 +的造血干细胞或祖细胞的数量因子宫内膜基质细胞或上皮细胞分泌的因子而增加。因此,可以消除在造血干细胞或祖细胞的移植中引起问题的生长因子,例如细胞因子和激素的添加,因此可以大量获得安全的造血干细胞或祖细胞。

著录项

  • 公开/公告号EP1904624B1

    专利类型

  • 公开/公告日2011-09-21

    原文格式PDF

  • 申请/专利权人 SEOUL NAT UNIV IND FOUNDATION;

    申请/专利号EP20050761298

  • 发明设计人 KANG KYUNG SUN;

    申请日2005-07-20

  • 分类号C12N5/0789;

  • 国家 EP

  • 入库时间 2022-08-21 17:58:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号